Cardiac assessment of patients with late stage Duchenne muscular dystrophy

Netherlands Heart Journal

Volumn 17, Issue 6, 2009, Pages 232-237

  Van Bockel, E A P ^a   Lind, J S ^b   Zijlstra, J G ^a   Wijkstra, P J ^a   Meijer, P M ^a   Van Den Berg, M P ^a   Slart, R H J A ^a   Aarts, L P H J ^c   Tulleken, J E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiomyopathy; Duchenne muscular dystrophy; Echocardiography; Home mechanical ventilation; Multigated radionuclide ventriculography; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMAGE QUALITY; IMMUNOASSAY; LIFE EXPECTANCY; MALE; MORTALITY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIOISOTOPE VENTRICULOGRAPHY; RESPIRATORY CARE; SCOLIOSIS; SCREENING;

EID: 70349283316     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086253     Document Type: Article

References (22)

1. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002 Naarden, the Netherlands. Neuromuscul Disord 2003;13:166-172
2. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 2003;99:1-19.
3. Silva MC, Meira ZM, Gurgel GJ, da Silva MM, Campos AF, Barbosa MM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 2007;49:1874-1879 (Pubitemid 46661108)
4. Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, et al. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovasc Imaging 2009;25:57-63.
5. Toussaint M, Steens M, Wasteels G, Soudon P. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J 2006;28:549-555 (Pubitemid 44794669)
6. Yasuma F, Konagaya M, Sakai M, Kuru S, Kawamura T. A new lease on life for patients with Duchenne muscular dystrophy in Japan. Am J Med 2004;117:363. (Pubitemid 39164572)
7. Oguz D, Olgunturk R, Gucuyener K, Acikgoz GV, Tunaoglu FS. A comparison between MUGA and echocardiography in patients with muscular dystrophy in the early detection of cardiac involvement. Pediatr Cardiol 1998;19:150-154 (Pubitemid 28092881)
8. Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC Jr, Francis GS, et al. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 2004;10(5 Suppl 3):1-30.
9. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167 (Pubitemid 34764819)
10. Mori K, Manabe T, Nii M, Hayabuchi Y, Kuroda Y, Tatara K. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatr Cardiol 2002;23:160-166 (Pubitemid 36927893)
11. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 2003;42:954-970
12. van der Vleuten PA, Slart RH, Tio RA, van der Horst IC, van Veldhuisen DJ, Dierckx RA et al. The feasibility of repeated left ventricular ejection fraction analysis with sequential single-dose radionuclide ventriculography. Nucl Med Commun 2005;26:711-715
13. Demachi J, Kagaya Y, Watanabe J, Sakuma M, Ikeda J, Kakuta Y et al. Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy. Neuromuscul Disord 2004;14:732-739 (Pubitemid 39346380)
14. Ishikawa Y, Bach JR, Minami R. Cardioprotection for Duchenne's muscular dystrophy. Am Heart J 1999;137:895-902.
15. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 2005;149:744-750 (Pubitemid 40501504)
16. Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, et al. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2002;89:838-841 (Pubitemid 34241462)
17. Mertens L, Ganame J, Claus P, Goemans N, Thijs D, Eyskens B, et al. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J Am Soc Echocardiogr 2008;21:1049-1054
18. Mohyuddin T, Jacobs IB, Bahler RC. B-type natriuretic peptide and cardiac dysfunction in Duchenne muscular dystrophy. Int J Cardiol 2007;119:389-391 (Pubitemid 46921256)
19. Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1999;9:347-351 (Pubitemid 29301718)
20. Adachi K, Kawai H, Saito M, Naruo T, Kimura C, Mine H, et al. Plasma levels of brain natriuretic peptide as an index for evaluation of cardiac function in female gene carriers of Duchenne muscular dystrophy. Intern Med 1997;36:497-500. (Pubitemid 127513214)
21. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Becane HM. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005;45:855-857 (Pubitemid 40342808)
22. Ramaciotti C, Scott WA, Lemler MS, Haverland C, Iannaccone ST. Assessment of cardiac function in adolescents with Duchenne muscular dystrophy: importance of neurohormones. J Child Neurol 2002;17:191-194 (Pubitemid 34704912)